Weight loss results vary from person to person.
In the OASIS 4 clinical trial, Wegovy Pill achieved an average weight loss of 16.6% over 64 weeks in patients who adhered fully to treatment, with around 1 in 3 losing 20% or more of their body weight.
These figures are averages and individual results can vary. No specific amount of weight loss can be guaranteed. Your result will depend on several factors, including how consistently you take the treatment, your dose, how well you tolerate the medicine, your lifestyle and your individual response.
Wegovy Pill is intended to support weight management alongside diet and lifestyle changes. It is not a replacement for long-term healthy habits.